لزوم ثبت فرآورده های NOXAFIL ، INFLUENZA VACCINE ، ROMIPLOSTIM، DOXORUBICIN SUSPENSION در سامانه TTAC

۱۴ مهر ۱۴۰۰ | ۱۳:۲۰ کد : ۲۰۸۰۲ اخبار اصلی
تعداد بازدید:۳۲۶
لزوم ثبت فرآورده های NOXAFIL ، INFLUENZA VACCINE ، ROMIPLOSTIM، DOXORUBICIN SUSPENSION در سامانه TTAC
ردیف دارو
1 ACTIVATED PROTHROMBIN COMPLEX (CONCENTRATED) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 1000 [iU]  
2 ACTIVATED PROTHROMBIN COMPLEX (CONCENTRATED) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 500 [iU]  
3 ADALIMUMAB INJECTION, SOLUTION PARENTERAL 50 mg/1mL 0.8 mL
4 ANAGRELIDE HYDROCHLORIDE CAPSULE ORAL 500 ug  
5 ANTITHYMOCYTE IMMUNOGLOBULIN INJECTION PARENTERAL 50 mg/1mL 5 mL
6 ANTITHYMOCYTE IMMUNOGLOBULIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 25 mg  
7 APOMORPHINE HYDROCHLORIDE INJECTION PARENTERAL 10 mg/1mL 3 mL
8 APOMORPHINE HYDROCHLORIDE INJECTION PARENTERAL 5 mg/1mL 20 mL
9 ASPARAGINASE 10,000U VIAL
10 BEVACIZUMAB INJECTION, SOLUTION, CONCENTRATE PARENTERAL 25 mg/1mL 16 mL
11 BEVACIZUMAB INJECTION, SOLUTION, CONCENTRATE PARENTERAL 25 mg/1mL 4 mL
12 BORTEZOMIB INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 3.5 mg mg
13 BUDESONIDE / FORMOTEROL FUMARATE POWDER, METERED RESPIRATORY 160 ug/4.5 ug/1{dose} 60 {dose}
14 BUSULFAN TABLET ORAL 2 mg
15 CALCIUM FOLINATE INJECTION PARENTERAL 
16 CICLOSPORIN INJECTION, SOLUTION INTRAVENOUS 50 mg/1mL 1 mL
17 CICLOSPORIN INJECTION, SOLUTION INTRAVENOUS 50 mg/1mL 5 mL
18 CICLOSPORIN SOLUTION ORAL 100 mg/1mL 50 mL
19 CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION PARENTERAL 200 mg  
20 CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION PARENTERAL 500 mg  
21 CYCLOPHOSPHAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 1 g  
22 CYCLOPHOSPHAMIDE TABLET ORAL 50 mg  
23 DAPSONE TABLET ORAL 100 mg
24 DEFEROXAMINE MESYLATE INJECTION, POWDER, FOR SOLUTION PARENTERAL 500 mg  
25 DIAZOXIDE 100MG CAP
26 DIAZOXIDE 50MG cap
27 ENOXAPARIN SODIUM INJECTION PARENTERAL 100 mg/1mL 
28 EPHEDRINE HCL 30MG TAB
29 ESTRAMUSTINE SODIUM PHOSPHATE CAPSULE ORAL 140 mg  
30 ETANERCEPT INJECTION, SOLUTION SUBCUTANEOUS 25 mg/0.5mL  
31 ETANERCEPT INJECTION, SOLUTION SUBCUTANEOUS 50 mg/1mL 1 mL
32 ETHIODIZED OIL INJECTION PARENTERAL 10 mL  
33 ETOPOSIDE 100MG CAP
34 ETOPOSIDE 50MG CAP
35 ETOPOSIDE INJECTION, SOLUTION INTRAVENOUS 20 mg/1mL 5 mL
36 EVEROLIMUS TABLET ORAL 0.25 mg
37 EVEROLIMUS TABLET ORAL 0.75 mg  
38 EVEROLIMUS TABLET ORAL 10 mg
39 EVEROLIMUS TABLET ORAL 5 mg
40 EVOLOCUMAB INJECTION PARENTERAL 140 mg/1mL  
41 FACTOR IX INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 1000 [iU]  
42 FACTOR VIII / VON WILLEBRAND FACTOR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 500 [iU]/1200 [iU]  
43 FACTOR VIII / VON WILLEBRAND FACTOR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 500 [iU]/500 [iU]  
44 FACTOR XIII INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 250 [iU]  
45 FIBRINOGEN INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g  
46 FORMOTEROL FUMARATE CAPSULE RESPIRATORY 12 ug  
47 GADOBUTROL INJECTION PARENTERAL 604.72 mg/1mL 15 mL
48 GADOBUTROL INJECTION PARENTERAL 604.72 mg/1mL 7.5 mL
49 GOSERELIN ACETATE IMPLANT PARENTERAL 10.8 mg  
50 GOSERELIN ACETATE IMPLANT PARENTERAL 3.6 mg  
51 INFLIXIMAB INJECTION, POWDER, FOR SOLUTION PARENTERAL 100 mg  
52 INTERFERON BETA-1A INJECTION PARENTERAL 12000000 [iU] 0.5 mL
53 IRON (AS SUCROSE) INJECTION INTRAVENOUS 20 mg/1mL 5 mL
54 ISOPROTERENOL INJECTION, 0.2 MG/ML 
55 LIRAGLUTIDE INJECTION, SOLUTION PARENTERAL 6 mg/1mL 3 mL
56 MELPHALAN 50MG VIAL
57 METHYLENE BLUE INJECTION PARENTERAL 10 mg/1mL 5 mL
58 MILRINONE LACTATE INJECTION, SOLUTION PARENTERAL 1 mg/1mL 10 mL
59 MINOXIDIL 10MG TAB
60 MITOTANE 500MG TAB
61 MYCOPHENOLATE MOFETIL TABLET ORAL 250 mg  
62 MYCOPHENOLATE MOFETIL TABLET ORAL 500 mg  
63 MYCOPHENOLIC ACID TABLET, DELAYED RELEASE ORAL 360 mg  
64 NATALIZUMAB INJECTION, SOLUTION, CONCENTRATE PARENTERAL 20 mg/1mL 15 mL
65 NATAMYCIN 5% OPH DROP
66 NIMODIPINE 30 MG TAB
67 NOREPINEPHRINE (AS BITARTRATE) INJECTION PARENTERAL 0.1 % 10 mL
68 NOREPINEPHRINE (AS BITARTRATE) INJECTION PARENTERAL 0.1 % 4 mL
69 OMALIZUMAB 150MG INJECTION
70 PANITUMUMAB INJECTION, SOLUTION, CONCENTRATE PARENTERAL 20 mg/1mL 20 mL
71 PANITUMUMAB INJECTION, SOLUTION, CONCENTRATE PARENTERAL 20 mg/1mL 5 mL
72 PAPAVERINE HCL 40MG/ML AMP
73 POSACONAZOLE INJECTION, SOLUTION, CONCENTRATE PARENTERAL 300 mg/16.7mL  
74 POSACONAZOLE SUSPENSION ORAL 40 mg/1mL 105 mL
75 PROPAFENONE HCL 150MG TAB
76 PROPAFENONE HCL 300MG TAB
77 RASBURICASE INJECTION, POWDER, FOR SOLUTION PARENTERAL 1.5 mg  
78 RITUXIMAB INJECTION PARENTERAL 
79 SIROLIMUS TABLET ORAL 1 mg  
80 SPECTINOMYCIN INJECTION, POWDER, FOR SOLUTION PARENTERAL 2 g
81 SPIRAMYCIN 500MG TAB
82 STREPTOMYCIN INJECTION 1 g
83 TACROLIMUS CAPSULE ORAL  0.5 mg  
84 TACROLIMUS CAPSULE ORAL 1 mg 
85 THIOPENTAL SODIUM INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g  -500
86 VERTEPORFIN (VISUDYNE)
87 VIGABATRIN TABLET ORAL 500 mg  
88 VINBLASTINE SULFATE INJECTION, POWDER, FOR SOLUTION PARENTERAL 10 mg
89 VINCRISTINE SULFATE INJECTION PARENTERAL 1 mg/1mL

لینک دانلود فایل

کلید واژه ها: لزوم ثبت فرآورده های در تیتک

نظر شما :